logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
C

Cancer Immunology Immunotherapy

IF5.1
Papers138
Citations
Journal Papers 138
Publication Date
delete
Sequential therapy with immune checkpoint inhibitors and dendritic cells for advanced hepatocellular carcinoma
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-05
delete0
deleteOAAI
deleteWei-Chen Lee; Yu-Chao Wang; Tsung-Han Wu; Yin Lai; Hao-Chien Hung; Jin-Chiao Lee; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan
deleteShare
deleteSave
iPSC-derived feeder platforms potentiate natural killer cell Immunotherapy
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-05
delete0
deleteOAAI
deleteZhi-Qian Lin; Yi-Chen Sun; Chia-Wei Chang; Chieh-Min Wang; Bing-Hong Chen; Lee-Yieng Lim; Yi-Ching Tsai; Cheng-Hsien Wu; Sheng-Hsuan Chien; Yi-Ping Yang; Shih-Hwa Chiou; Kai-Feng Hung
deleteShare
deleteSave
N-methyl-D-aspartate (NMDA) ion channels drive calcium-dependent myeloid cell reprogramming to shape cancer immunity and immunotherapy
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-05
delete0
deleteOAAI
deleteDagmara Dymerska Zaremba; Anna M. Czarnecka; Patrycja Wińska
deleteShare
deleteSave
Regulatory B cells and the microbiome: implications for checkpoint blockade therapy in cancer
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-02
delete0
deleteOAAI
deleteAkshay J. Patel; Gary W. Middleton
deleteShare
deleteSave
A phase II pilot trial of an indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor (INCB024360) plus a multipeptide melanoma vaccine (MELITAC 12.1) in patients with advanced melanoma, with sequential evaluation of the tumor microenvironment
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-02
delete0
deleteOAAI
deleteCraig L. Slingluff; Marc S. Ernstoff; David Lawson; Keith A. Delman; Brent A. Hanks; Brian Gastman; Ileana S. Mauldin; Walter C. Olson; Emily K. Ninmer; Sarah E. Gradecki; Kelly T. Smith; Alejandro Gru; Nirasha Ramchurren; Chihiro Morishima; Steven P. Fling; Judith C. Kaiser; Martin A. Cheever
deleteShare
deleteSave
TREM2 blockade reprograms HER2 CAR macrophages toward inflammatory phagocytes in breast cancer models
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-01
delete0
deleteOAAI
deleteJassaud Marius; Ziane-Chaouche Lydia; Raffo-Romero Antonella; Salzet Michel; Duhamel Marie
deleteShare
deleteSave
Dynamics of peripheral blood NKT cells and PD-L1-expressing classical monocytes as immune correlates of radiotherapy-primed atezolizumab in relapsed small cell lung cancer: a phase II study
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-01
delete0
deleteOAAI
deleteYang-Gun Suh; Youngjoo Lee; Sung Ho Moon; Seojin Lee; Ji-Youn Han
deleteShare
deleteSave
Transcription factor RBPJ improves the efficacy of PD-1/PD-L1-based therapies in non-small cell lung cancer by expanding CD8+ tissue-resident memory T cells
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-10-01
delete0
deleteOAAI
deleteGaoming Liao; Qi Liu; Min Zhang; Yan Liu; Jinwei Li; Si Huang; Jian Shi; Xionghai Qin
deleteShare
deleteSave
Radiotherapy drives PD-1 expression on monocytes to attenuate anti-tumor immunity
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteJiandong Zhang; Chen Chen; Qiuyu Mu; Yuzhu Hou; Xiaozhi Zhang
deleteShare
deleteSave
Radiation potentiates natural killer cell therapy combined with Atezolizumab and Bevacizumab in SNU-398 hepatocellular carcinoma models
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteGa-Young Park; Woo-Chang Son; Hong-Rae Lee; Hyun Bon Kang; Won-Tae Kim; Yu Jeong Yoon; Wan Jeon; Sang Youn Hwang; YoungHee Kim; You-Soo Park
deleteShare
deleteSave
Porphyromonas gingivalis adhesion protein Mfa1 enhances the anti-cancer effect of anti–PD-L1 antibody by immune activation
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteEun-Koung An; Wei Zhang; Minjun Jung; Hae-Bin Park; So-Jung Kim; Dayoung Ryu; Eunseo Jeong; Minhyuk Lee; Yi Xu; Peter C. W. Lee; Wonpil Im; Jun-O Jin
deleteShare
deleteSave
Seasonal variations in overall survival and vitamin D status in a UK pan-cancer cohort receiving checkpoint inhibitors
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-29
delete0
deleteOAAI
deleteOliver Kennedy; Nadia Ali; Rebecca Lee; Safwaan Adam; Fiona Helen Blackhall; Raffaele Califano; Tim Cooksley; Laura Cove-Smith; Victoria Foy; Avinash Gupta; Robert Metcalf; Phillip J. Monaghan; Manon Rhys Pillai; Patricio Serra-Bellver; Yvonne Summers; Tom Waddell; Paul Lorigan
deleteShare
deleteSave
Targeting the NOTCH1 signaling pathway in chronic lymphocytic leukemia enhances the efficacy of CD19 CAR-T cells
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-27
delete0
deleteOAAI
deleteHuijian Zheng; Huajian Xian; Chaoqun Lu; Wenjie Zhang; Yixin Wang; Minghui Wang; Shuqiong Lin; Shiming Chen; Zixuan Huang; Yaoyifu Yu; Yuling Zheng; Yumenglin Bai; Han Liu; Zhenshu Xu
deleteShare
deleteSave
Efficacy and safety of adjuvant sintilimab monotherapy in high-risk resected esophageal squamous cell carcinoma: a prospective, single-arm phase II trial
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-27
delete0
deleteOAAI
deleteShaolei Li; Xinrun Cui; Dachuan Zhao; Ye Tao; Shanyuan Zhang; Fangliang Lu; Shi Yan; Jia Wang; Jingfeng Chen; Nan Wu
deleteShare
deleteSave
Tumor-suppressive and immunomodulatory roles of BPIFB1/LPLUNC1: mechanistic insights from nasopharyngeal carcinoma and implications for multi-system diseases
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-25
delete0
deleteOAAI
deleteJiaodi Cai; Feng Jiang; Li Xiao; Wenqin Zhang
deleteShare
deleteSave
Adding nivolumab to definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma: a propensity score matching study
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-25
delete0
deleteOAAI
deleteMing-Wei Kao; Kun-Chou Hsieh; Wen-Lun Wang; Shyh-An Yeh; Kuei-Kang Huang; Meng-Che Hsieh
deleteShare
deleteSave
Revisiting human circulating γδ T cells: developmental insights and manufacturing challenges for cancer immunotherapy
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-24
delete0
deleteOAAI
deleteJeng-Rong Lin; Lakshay Kapil; Huan-An Tsai; Wen-Chieh Liao; Yu-Cheng Chou; Chiung-Hui Liu
deleteShare
deleteSave
Decoding macrophage polarization heterogeneity in post-chemotherapy AML microenvironments
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-24
delete0
deleteOAAI
deletePei Zhu; Wenjuan Zhang; Zhihua Wu; Yuping Deng; Xiaojuan Huang; Lin Fu
deleteShare
deleteSave
Molecular regulatory network of PD-L1 expression under Helicobacter pylori infection and its clinical translational value: a review of multi-pathway crosstalk mechanisms
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-23
delete0
deleteOAAI
deleteQiwei Wang; Tianjiao Duan; Juju Feng; Linqing Sun; Jia Wei; Yanhui Zhang; Aqian Song; Tiantian Gao; Yun Feng
deleteShare
deleteSave
CYP2S1: a novel regulator of PMN-MDSC recruitment and immunotherapy resistance in esophageal squamous cell carcinoma
deleteCancer Immunology Immunotherapy
IF5.1
delete2026-09-22
delete0
deleteOAAI
deleteXiaoyan Li; Chunning Li; Xiaoxi Li; Zhengda Li; Kuangjie Zhao; Mengdi Li; Lei Zhan; Yong Zhang; Qian Dong; Jingdong Zhang
deleteShare
deleteSave